Patents
Patents for C07C 259 - Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups (4,411)
08/2005
08/31/2005EP1567498A2 Mandelic acid derivatives
08/31/2005EP1567142A2 Treatment of lung cells with histone deacetylase inhibitors
08/30/2005US6936719 pyridine ring containing biaryl compound useful to treat and/or prevent clotting disorders, and as antiinflammatory and anticoagulant agents
08/25/2005US20050187265 Novel benzyl amidoxime derivatives, intermediate products and method for their production and use as fungicides
08/25/2005US20050187261 For hepatitis C; histone deacetylase inhibitors, anticarcinogenic agents; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides; amidation of a benzoic acid, benzoate, benzoyl halide with hydroxyamine
08/25/2005US20050186176 Compounds and compositions for delivering active agents
08/24/2005EP1565433A2 Novel ligands that are antagonists of rar receptors, process for preparing them and use thereof in human medicine and in cosmetics
08/23/2005US6933319 Resorcinol derivatives
08/23/2005CA2469592C Hiv integrase inhibitors
08/18/2005US20050182269 Process for the preparation of 3-cyano-1-naphthoic acid and some analogues thereof
08/18/2005US20050182137 Bacterial enzyme inhibitors
08/17/2005CN1656057A N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors
08/16/2005CA2232374C Phenylacetic acid derivatives, processes and intermediates for their preparation, and compositions comprising them
08/16/2005CA2166059C Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
08/11/2005WO2005073180A1 Hydroxamic acid derivative and age generation inhibitor containing the derivative
08/11/2005US20050176820 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
08/11/2005US20050176686 for HDACs (1-10) or Silent Information Regulator (SIR2) protein family; 3-Cyclopentyl-N-hydroxy-propionamide; antiproliferative agent for tumor cells and other abnormal gene expression
08/10/2005EP1561463A2 Benzamidoxime prodrugs as antipneumocystic agents
08/10/2005EP1157002B1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy
08/09/2005US6927228 Biphenyl compounds usefuf in treatment of human and veterinary medicines such as dermatology, cardivovascular diseases, immune diseases or diseases associated with lipid metabolisms, or in cosmetic formulation
08/04/2005WO2005054179A3 Hydroxamic acid esters and pharmaceutical use thereof
08/04/2005US20050171208 Histone deacetylase inhibitors
08/04/2005US20050171065 NAALADas, N-Acetylated-Alpha-Linked-Acidic-Dipeptidase inhibitors; 5-phosphonomethyl-1,3-benzenedicarboxylic Acid; glutamate abnormalities, anticancer, antidiabetic agent, angiogenesis inhibitor, neuropathy, pain, compulsive disorders, prostate diseases, glaucoma
08/03/2005EP1558574A1 Novel n-hydroxy thiourea, urea and amide compounds and the pharmaceutical compositions comprising the same
08/03/2005CN1213038C Benzophenones as inhibitors of reverse transcriptase
08/03/2005CN1213021C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors
08/03/2005CN1212835C Hydroxamate-containing cysteine and serine protease inhibitors
08/02/2005US6924391 Antiinflammatory agents; antitumor agent
08/02/2005US6924314 Compounds for the treatment of metabolic disorders
08/02/2005US6924307 Metalloproteinase inhibitor; antiarthritic agents, osteoporosis; cardiovascular disorders; antitumor agents; autoimmune diseases
08/02/2005CA2362339C Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
08/02/2005CA2362337C Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
07/2005
07/26/2005CA2133439C Compounds useful for treating allergic and inflammatory diseases
07/20/2005CN1642906A Novel arylamidine derivative or salt thereof
07/20/2005CN1211353C Unsaturated hydroximic acid derivatives as PARP inhibitors
07/14/2005WO2005063689A1 Benzamide derivative
07/14/2005US20050151973 Optical device utilizing plasmon resonance
07/13/2005CN1638757A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin
07/13/2005CN1636986A Benzophenones as inhibitors of reverse transcriptase
07/13/2005CN1636985A Benzophenones as inhibitors of reverse transcriptase
07/13/2005CN1636984A Benzophenones as inhibitors of reverse transcriptase
07/13/2005CN1210268C (Cyclo) alkyl substituted-gamma-aminobutyric acid derivatives (=GABA analogurs), their preparation and their use in the treatment of neurolog disorders
07/12/2005US6916848 Compounds for the treatment of metabolic disorders
07/07/2005WO2005061501A2 Process for preparing hexahydropyrimido[1,2-a]azepine-2-carboxylates and related compounds
07/07/2005WO2005037779A3 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
07/07/2005US20050148613 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
07/07/2005CA2547159A1 Process for preparing hexahydropyrimido[1,2-a]azepine-2-carboxylates and related compounds
07/06/2005EP1550856A2 Optical device for use in plasmon resonance
07/06/2005EP1549609A2 Propargylether derivatives, a process for their preparation and their use for controlling phytopathogenic microorganisms
07/05/2005CA2230082C Amide compounds and use thereof
06/2005
06/30/2005WO2005058803A1 Tricyclic hydroxamate and benzamide derivatives, compositions and methods
06/30/2005DE10355223A1 Neue Makrocyclen zur Behandlung von Krebserkrankungen New macrocycles for the treatment of cancer
06/29/2005CN1633413A 20-hydroxyeicosatetraenoic acid production inhibitors
06/29/2005CN1633412A Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
06/23/2005WO2005055928A2 Zn2+ -chelating motif-tethered short -chain fatty acids as a novel class of histone deacetylase inhibitors
06/23/2005US20050137263 e.g., 2-[(4-Ethyl-2-fluorophenyl)amino]-3,4-difluoro-N-(2-hydroxyethoxy)benzamide, is administered to treat arthritis
06/23/2005CA2552279A1 Zn2+-chelating motif-tethered short -chain fatty acids as a novel class of histone deacetylase inhibitors
06/22/2005EP1542968A1 Process for preparing intermediates
06/21/2005US6908911 Antibacterial agents
06/16/2005WO2005054179A2 Hydroxamic acid esters and pharmaceutical use thereof
06/16/2005WO2005053628A1 Use of osteopontin in dental formulations
06/16/2005WO2005053610A2 Diamine and iminodiacetic acid hydroxamic acid derivatives
06/16/2005US20050131018 Acetylene derivatives as inhibitors of histone deacetylase
06/16/2005CA2549242A1 Hydroxamic acid esters and pharmaceutical use thereof
06/16/2005CA2547356A1 Diamine and iminodiacetic acid hydroxamic acid derivatives
06/15/2005EP1541549A1 Tricyclic hydroxamate and benzaminde derivatives, compositions and methods
06/15/2005EP1256576B1 Fused imidazolium derivatives
06/15/2005CN1206209C Match of dihydroxytin mononuclear glycyl (or alanyl) hydroxamate and its synthesizing process
06/14/2005CA2304967C 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
06/09/2005WO2005051947A1 Thiaepothilone for treating cancerous diseases
06/09/2005WO2005051901A1 Anti-cancer agents
06/09/2005US20050124679 Alpha, beta-unsaturated hydroxamic acid derivatives and their use as histone deacetylase inhibitors
06/08/2005EP1537074A1 Cathepsin cysteine protease inhibitors
06/08/2005EP1309575B1 Biphenyl derivatives and their use as ppar-gamma receptor activators
06/08/2005EP0849256B1 Amide compounds and use of the same
06/08/2005CN1205180C 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds
06/08/2005CN1205179C (P-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
06/02/2005US20050119305 N-hydroxy-6-[(4-phenylbenzoyl)amino]hexanamide; hydroxamic acid derivative and equivalent thereof; antiinflammatory, anticarcinogenic, antiarthritic, antidiabetic agents; sepsis, leukemia, osteoporosis, skin disorders, cachexia, autoimmune diseases, hepatitis, endometriosis; hypergammaglobulinemia
06/01/2005EP1254136A4 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF
06/01/2005CN1204115C Match of binuclear dihydroxytin glycyl (or alanyl) hydroxamate
05/2005
05/31/2005US6900244 Controlling lipid, cholesterol metabolism; anticholesterol agents
05/26/2005US20050113451 7-acetamidinyl derivatives
05/26/2005US20050113424 E.g., 4-{3-[4-(3-{4-[amino(imino)methyl]phenoxy}propyl)-1-piperazinyl]propoxy}benzamidine; an antifungal agent with good pharmacokinetics and excellent antifungal action; side effect reduction such as nephrotoxicity; action to Mycomycetes
05/26/2005US20050113400 Novel benzophenone derivatives or salts thereof
05/26/2005US20050113366 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of $g(g)-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses
05/26/2005US20050113285 Biocompatible polymeric materials for medical implant devices
05/25/2005DE10348022A1 Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen New dipeptidyl peptidase IV inhibitors for the functional influence of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases
05/25/2005CN1620424A Compounds for the treatment of inflammatory disorders
05/24/2005US6897306 3-heterocyclylpropanohydroxamic acids
05/19/2005US20050107348 Contacting cells with a zinc-binding compounds, having effective amount of carboxylic acid derivative or hydroxamic acid derivative inhibitor compound; treating cancer, blood disorders, genetic related metabolic disorders; 3-methyl-5-phenyl-2,4-pentadienoic acid
05/19/2005DE10348023A1 Neue Alanyl-Aminopeptidasen-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen New alanyl aminopeptidase inhibitors for functional interference of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases
05/18/2005CN1617849A Hiv整合酶抑制剂 Hiv integrase inhibitors
05/12/2005US20050101671 Compounds and compositions for delivering active agents
05/11/2005EP0861071B1 Benzamidoxime prodrugs and use thereof for treating pneumonia
05/11/2005CN1615296A Carboxamidine derivatives and their use in the treatment of vascular diseases
05/10/2005US6891066 For therapy of cancer, restenosis, psoriasis, autoimmune disease, atherosclerosis, osteoarthritis, rheumatoid arthritis, heart failure, chronic pain, and neuropathic pain
05/10/2005CA2303801C Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
05/06/2005WO2005040098A1 Polymorphic form of n-[(r)-2,3-dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide
05/06/2005WO2005039498A2 Methods of treating cancer with hdac inhibitors
05/06/2005CA2543319A1 Methods of treating leukemia with suberoylanilide hydroxamic acid
1 ... 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ... 45